Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
Authors:
- Kiran J PhilipKPKiran J Philip
- Ernst R SchwarzErnst R Schwarz
Open Access
- 8 February 2011
- journal article
- review article
- Vol. 22 (1) , 38-44
Abstract
Fabry’s disease is an X-linked lysosomal storage disease most often associated with renal dysfunction and death due to renal failure in patients’ fourth and fifth decades of life. However, cardiac manifestations including arrhythmias, angina and heart failure are common and probably under-recognised. Furthermore, Fabry’s disease is now recognised as also affecting female carriers, who manifest signs later than males. A variant of Fabry’s has been identified that only affects cardiac tissue, which presents as an unexplained hypertrophy of the left ventricle in middle-aged patients, possibly with women more affected than men. Given that epidemiological studies report a prevalence of Fabry’s cardiomyopathy among middle-aged patients with cardiac hypertrophy to be anywhere from one to 12%, it is reasonable to screen these patients for alpha-galactosidase A deficiency. Although mortality data is lacking from randomised, controlled trials of galactosidase replacement therapy, there are some reports of improvement in cardiac endpoints. Therefore patients with known Fabry’s disease should be screened early for cardiac involvement, as treatment benefit may not be seen once cardiac fibrosis has developed.Keywords
This publication has 77 references indexed in Scilit:
- Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearanceClinical Physiology and Functional Imaging, 2009
- Long-Term Effects of Enzyme Replacement Therapy on Fabry CardiomyopathyCirculation, 2009
- Angina in Fabry Disease Reflects Coronary Small Vessel DiseaseCirculation: Heart Failure, 2008
- Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experienceJournal of Cardiovascular Medicine, 2007
- Delayed Contrast Enhancement Magnetic Resonance Imaging for the Assessment of Cardiac DiseaseHeart, Lung and Circulation, 2007
- Impact of Enzyme Replacement Therapy on Cardiac Morphology and Function and Late Enhancement in Fabry’s CardiomyopathyThe American Journal of Cardiology, 2006
- Fabry’s Disease CardiomyopathyJACC, 2006
- The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathyJACC, 2004
- Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease Evidence for a disease specific abnormality of the myocardial interstitiumEuropean Heart Journal, 2003
- Prevalence of Anderson-Fabry Disease in Male Patients With Late Onset Hypertrophic CardiomyopathyCirculation, 2002